Increasing evidence supports a close relevance between EZH2 expression and human malignancies, for instance that of EZH2 was highly expressed in bladder [39], breast [40], endometrial [41], and prostate cancer [42] correlating with tumor progression. Here, EZH2 is linked to prostate cancer.